Acute hypertension inhibits thirst stimulated by ANG II, hyperosmolality, or hypovolemia in rats.
The present study sought to determine whether increases in arterial blood pressure inhibited drinking behavior evoked by ANG II, hyperosmolality, or hypovolemia in rats. Cumulative water intakes in 60- or 90-min tests and latency to the first lick were recorded as indexes of thirst. During intravenous infusions of 100 ng. kg(-1). min(-1) ANG II, attenuation of the induced increases in arterial pressure with the arteriolar vasodilator diazoxide resulted in greater water intakes and shorter latencies to drink. Drinking behavior stimulated by intravenous infusion of hypertonic saline was significantly inhibited by increases in arterial pressure caused by intravenous infusion of phenylephrine or endothelin-1, and this inhibition of drinking was proportional to the induced increase in pressure. Upon termination of the phenylephrine infusion, mean arterial pressure returned to basal values, and drinking was restored. Phenylephrine-induced increases in arterial pressure also inhibited drinking behavior in response to hypovolemia that could not be explained by differences in plasma renin activity, plasma protein concentration, or plasma osmolality. Thus increases in arterial pressure inhibit water drinking behavior in response to each of these three thirst stimuli in rats.
Stocker
S D
SD
Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
Stricker
E M
EM
Sved
A F
AF
D000208:Acute Disease; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D004326:Drinking / Q000187:drug effects / Q000502:physiology; D004327:Drinking Behavior / Q000187:drug effects / Q000502:physiology; D019332:Endothelin-1 / Q000494:pharmacology; D006973:Hypertension / Q000503:physiopathology*; D020896:Hypovolemia / Q000503:physiopathology*; D007262:Infusions, Intravenous; D008297:Male; D009997:Osmotic Pressure; D010656:Phenylephrine / Q000494:pharmacology; D011092:Polyethylene Glycols / Q000494:pharmacology; D011188:Potassium / Q000652:urine; D011311:Pressoreceptors / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012462:Saline Solution, Hypertonic / Q000494:pharmacology; D012964:Sodium / Q000652:urine; D012997:Solvents / Q000494:pharmacology; D013894:Thirst / Q000187:drug effects / Q000502:physiology*; D014556:Urine; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D019332:Endothelin-1; D012462:Saline Solution, Hypertonic; D012997:Solvents; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D010656:Phenylephrine; D011092:Polyethylene Glycols; D012964:Sodium; D011188:Potassium